BIOAGE LABS, INC. OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax
BIOAGE LABS, INC. (BIOA) reported OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax of -$547.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax · last filed 2026-08-05
- BIOAGE LABS, INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2026-06-30 was -$547.00K.
- BIOAGE LABS, INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2026-03-31 was -$178.00K, a 713.79% decline year-over-year.
- BIOAGE LABS, INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2025-09-30 was $73.00K.
- BIOAGE LABS, INC. oci, debt securities, available-for-sale, gain (loss), after adjustment, before tax for the quarter ending 2025-03-31 was $29.00K.
| Period end | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 3 month | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax 6 month |
|---|---|---|
| 2026-06-30 | -$547.00K 10-Q · filed 2026-08-05 | -$725.00K derived: sum of 2 quarters · filed 2026-08-05 |
| 2026-03-31 | -$178.00K 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $73.00K 10-Q · filed 2025-11-06 | |
| 2025-03-31 | $29.00K 10-Q · filed 2026-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |